Payment overview · 2025
General Payments
$252.55
6 reported records · 5 companies
Healthcare provider profile · identity verified
Hamid Eskandari, MD
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · FOOTHILL RANCH, CA · NPI 1063662682
Verified facts
What the public records show
CMS Open Payments records show Hamid Eskandari, MD received $252.55 in general payments during 2025 across 6 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 46.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $117.34 | 46.5% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $57.22 | 22.7% | 2 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $37.50 | 14.8% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $22.04 | 8.7% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $18.45 | 7.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $252.55 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $139.38 | 2 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $57.22 | 2 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $37.50 | 1 | 2025 |
Source payment records
|
|||||
| HETLIOZ Normalized: hetlioz |
Drug | Vanda Pharmaceuticals Inc. | $37.50 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $18.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1107 | 254 |
| Levothyroxine Sodium | Levothyroxine Sodium | 772 | 165 |
| Eliquis | Apixaban | 574 | 61 |
| Metformin Hcl | Metformin Hcl | 566 | 155 |
| Amlodipine Besylate | Amlodipine Besylate | 563 | 145 |
| Losartan Potassium | Losartan Potassium | 520 | 142 |
| Gabapentin | Gabapentin | 497 | 116 |
| Tamsulosin Hcl | Tamsulosin Hcl | 467 | 110 |
| Famotidine | Famotidine | 466 | 114 |
| Omeprazole | Omeprazole | 463 | 109 |
| Furosemide | Furosemide | 458 | 92 |
| Metoprolol Tartrate | Metoprolol Tartrate | 383 | 84 |
| Donepezil Hcl | Donepezil Hcl | 382 | 75 |
| Pantoprazole Sodium | Pantoprazole Sodium | 367 | 92 |
| Quetiapine Fumarate | Quetiapine Fumarate | 340 | 58 |
| Lisinopril | Lisinopril | 325 | 68 |
| Simvastatin | Simvastatin | 322 | 66 |
| Mirtazapine | Mirtazapine | 315 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 314 | 71 |
| Sertraline Hcl | Sertraline Hcl | 288 | 68 |
| Potassium Chloride | Potassium Chloride | 270 | 59 |
| Zolpidem Tartrate | Zolpidem Tartrate | 243 | 49 |
| Trazodone Hcl | Trazodone Hcl | 232 | 57 |
| Memantine Hcl | Memantine Hcl | 217 | 44 |
| Lorazepam | Lorazepam | 211 | 50 |
| Baclofen | Baclofen | 209 | 28 |
| Alprazolam | Alprazolam | 207 | 43 |
| Alendronate Sodium | Alendronate Sodium | 204 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 204 | 49 |
| Carvedilol | Carvedilol | 203 | 44 |
| Xarelto | Rivaroxaban | 202 | 19 |
| Divalproex Sodium | Divalproex Sodium | 195 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 194 | 67 |
| Escitalopram Oxalate | Escitalopram Oxalate | 192 | 52 |
| Oxycodone Hcl | Oxycodone Hcl | 187 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 173 | 28 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 172 | 101 |
| Vascepa | Icosapent Ethyl | 169 | 46 |
| Linzess | Linaclotide | 163 | 43 |
| Hydralazine Hcl | Hydralazine Hcl | 161 | 62 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 155 | 61 |
| Azithromycin | Azithromycin | 155 | 117 |
| Levetiracetam | Levetiracetam | 155 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 154 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 150 | 56 |
| Januvia | Sitagliptin Phosphate | 149 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 148 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 146 | 57 |
| Tramadol Hcl | Tramadol Hcl | 143 | 28 |
| Myrbetriq | Mirabegron | 140 | 22 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 136 | 18 |
| Allopurinol | Allopurinol | 135 | 29 |
| Warfarin Sodium | Warfarin Sodium | 132 | suppressed |
| Lacosamide | Lacosamide | 129 | suppressed |
| Finasteride | Finasteride | 126 | 34 |
| Jardiance | Empagliflozin | 126 | 25 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 121 | 14 |
| Montelukast Sodium | Montelukast Sodium | 121 | 24 |
| Clonazepam | Clonazepam | 120 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 119 | 56 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 118 | 45 |
| Lactulose | Lactulose | 118 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 115 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 115 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 114 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 111 | 25 |
| Latanoprost | Latanoprost | 106 | 27 |
| Fenofibrate | Fenofibrate Nanocrystallized | 101 | 22 |
| Atenolol | Atenolol | 99 | 27 |
| Ozempic | Semaglutide | 94 | 18 |
| Tradjenta | Linagliptin | 91 | suppressed |
| Prednisone | Prednisone | 88 | 23 |
| Digoxin | Digoxin | 86 | suppressed |
| Humulin R | Insulin Regular, Human | 82 | 16 |
| Glipizide | Glipizide | 81 | 15 |
| Celecoxib | Celecoxib | 80 | 34 |
| Midodrine Hcl | Midodrine Hcl | 79 | 12 |
| Risperidone | Risperidone | 77 | 11 |
| Nystatin | Nystatin | 75 | 41 |
| Cephalexin | Cephalexin | 74 | 50 |
| Buspirone Hcl | Buspirone Hcl | 73 | 13 |
| Lovastatin | Lovastatin | 71 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 70 | 21 |
| Clonidine Hcl | Clonidine Hcl | 68 | 26 |
| Icosapent Ethyl | Icosapent Ethyl | 68 | 28 |
| Humalog Kwikpen U-100 | Insulin Lispro | 67 | 14 |
| Spironolactone | Spironolactone | 67 | 11 |
| Hydrocortisone | Hydrocortisone | 66 | 26 |
| Pregabalin | Pregabalin | 65 | 11 |
| Bupropion Xl | Bupropion Hcl | 63 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 63 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 62 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 49 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 60 | 35 |
| Buprenorphine Hcl | Buprenorphine Hcl | 59 | suppressed |
| Meloxicam | Meloxicam | 59 | 16 |
| Mupirocin | Mupirocin | 59 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 57 | 37 |
| Lamotrigine | Lamotrigine | 56 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 56 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 15 |
| Pradaxa | Dabigatran Etexilate Mesylate | 55 | suppressed |
| Methadone Hcl | Methadone Hcl | 54 | suppressed |
| Oxycontin | Oxycodone Hcl | 54 | suppressed |
| Prolia | Denosumab | 54 | 30 |
| Olanzapine | Olanzapine | 52 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 51 | 14 |
| Benazepril Hcl | Benazepril Hcl | 50 | 11 |
| Valsartan | Valsartan | 50 | 17 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 49 | 12 |
| Ketoconazole | Ketoconazole | 49 | 13 |
| Belsomra | Suvorexant | 48 | 13 |
| Terazosin Hcl | Terazosin Hcl | 48 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 46 | 11 |
| Lidocaine | Lidocaine | 45 | 11 |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 45 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 44 | 15 |
| Novolog Flexpen | Insulin Aspart | 43 | suppressed |
| Enulose | Lactulose | 42 | suppressed |
| Methocarbamol | Methocarbamol | 42 | 13 |
| Methotrexate | Methotrexate Sodium | 42 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 42 | 42 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 42 | suppressed |
| Aripiprazole | Aripiprazole | 41 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 41 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 41 | 12 |
| Ezetimibe | Ezetimibe | 40 | 16 |
| Ondansetron Odt | Ondansetron | 40 | 17 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 39 | 12 |
| Cyclosporine | Cyclosporine | 39 | suppressed |
| Gemfibrozil | Gemfibrozil | 39 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 39 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 38 | 11 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | suppressed |
| Budesonide | Budesonide | 37 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Clozapine | Clozapine | 36 | suppressed |
| Nitroglycerin | Nitroglycerin | 36 | 16 |
| Restasis | Cyclosporine | 36 | suppressed |
| Sucralfate | Sucralfate | 36 | suppressed |
| Timolol Maleate | Timolol Maleate | 36 | suppressed |
| Phenobarbital | Phenobarbital | 35 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | suppressed |
| Enbrel | Etanercept | 34 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 33 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 33 | 11 |
| Metformin Hcl Er | Metformin Hcl | 32 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 32 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Ibuprofen | Ibuprofen | 31 | 26 |
| Trulicity | Dulaglutide | 31 | suppressed |
| Diazepam | Diazepam | 30 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 30 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Letrozole | Letrozole | 28 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Verapamil Er | Verapamil Hcl | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Levemir Flexpen | Insulin Detemir | 25 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | suppressed |
| Folic Acid | Folic Acid | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Ingrezza | Valbenazine Tosylate | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 19 |
| Methylprednisolone | Methylprednisolone | 24 | 15 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 24 | 13 |
| Santyl | Collagenase Clostridium Hist. | 24 | 11 |
| Sodium Chloride | Sodium Chloride 0.45 % | 24 | 18 |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Torsemide | Torsemide | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 22 | 12 |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 21 | 13 |
| Memantine Hcl Er | Memantine Hcl | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | 12 |
| Amoxicillin | Amoxicillin | 20 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 16 |
| Desmopressin Acetate | Desmopressin Acetate | 20 | suppressed |
| Erythromycin | Erythromycin Base | 20 | 14 |
| Estradiol | Estradiol | 20 | 14 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 18 | 14 |
| Clonidine | Clonidine | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 18 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Ambien Cr | Zolpidem Tartrate | 17 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 17 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 17 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 16 | suppressed |
| Plavix | Clopidogrel Bisulfate | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Clotrimazole | Clotrimazole | 15 | suppressed |
| Glyburide | Glyburide | 15 | suppressed |
| Olanzapine Odt | Olanzapine | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Sulfasalazine | Sulfasalazine | 15 | suppressed |
| Xanax | Alprazolam | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Novolin R | Insulin Regular, Human | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Nexlizet | Bempedoic Acid/Ezetimibe | 12 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 12 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $252.55 · 6 records | Otsuka America Pharmaceutical, Inc. | AIRSUPRA, AUSTEDO XR, FANAPT, HETLIOZ, REXULTI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error